Genomic sequencing in clinical trials

Karen K. Mestan*, Leonard Ilkhanoff, Samdeep Mouli, Simon Lin

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations

Abstract

Human genome sequencing is the process by which the exact order of nucleic acid base pairs in the 24 human chromosomes is determined. Since the completion of the Human Genome Project in 2003, genomic sequencing is rapidly becoming a major part of our translational research efforts to understand and improve human health and disease. This article reviews the current and future directions of clinical research with respect to genomic sequencing, a technology that is just beginning to find its way into clinical trials both nationally and worldwide. We highlight the currently available types of genomic sequencing platforms, outline the advantages and disadvantages of each, and compare first- and next-generation techniques with respect to capabilities, quality, and cost. We describe the current geographical distributions and types of disease conditions in which these technologies are used, and how next-generation sequencing is strategically being incorporated into new and existing studies. Lastly, recent major breakthroughs and the ongoing challenges of using genomic sequencing in clinical research are discussed.

Original languageEnglish (US)
Article number222
JournalJournal of Translational Medicine
Volume9
Issue number1
DOIs
StatePublished - Dec 30 2011

Keywords

  • Bioinformatics
  • Clinical trial
  • Dna
  • Human genome
  • Sequencing

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Genomic sequencing in clinical trials'. Together they form a unique fingerprint.

Cite this